FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282836413> ?p ?o ?g. }

• W4282836413 endingPage "238" @default.
• W4282836413 startingPage "226" @default.
• W4282836413 abstract "Abstract Background The age‐related loss of muscle mass and quality, sarcopenia, has many contributing factors, one of which may be cellular senescence, but this is not well defined in human skeletal muscle. Method Primary cells were isolated from biopsy samples of the vastus lateralis muscle from healthy adult males ( n = 6, 22 ± 1 years), sorted (magnetic activated cell sorting) and chemically induced (doxorubicin, DOX, 0.2 μM) to a senescent state. This allowed the parallel and simultaneous investigation of the two main skeletal muscle‐derived cell types: satellite cell‐derived CD56 +ve /desmin +ve myoblasts (muscle precursor cells) and CD56 − ve /TE7 +ve fibroblasts (at >95% purity). Both cell types were followed for up to 35 days post DOX treatment with a combination of quantitative immunocytochemistry and qRT‐PCR for senescent markers and senescence‐associated secretory phenotype (SASP) factors. Results Myoblasts and fibroblasts showed temporal and quantitative differences in many of the senescence markers studied. p16 protein expression increased across the time course ( P < 0.0001) with no difference between cell types, whereas at the mRNA level, myoblasts showed increased p16 expression from 4 days post treatment (FC = 3.03 ± 0.99), and in fibroblasts, this appeared later at 10 and 35 days post DOX treatment (FC = 8.09 ± 2.46, P < 0.0001). Both myoblasts (FC = 8.83 ± 1.72) and fibroblasts (FC = 2.33 ± 1.10) showed significant increases in p21 mRNA ( P < 0.0001), which remained elevated in the myoblast cell populations across the 35‐day time course but returned to baseline in the fibroblasts from 4 days post DOX treatment. Within 35 days post DOX treatment, all cell populations of both myoblasts and fibroblasts had reached 100% SA‐β‐Gal‐positive cells ( P < 0.05). γH2aX expression (a marker of DNA damage) increased 1 day after DOX treatment in the myoblasts (FC = 3.3 ± 1.1, P < 0.05) but returned to baseline within 4 days post DOX treatment, whereas fibroblasts showed a similar trend that did not reach statistical significance. Significant reductions in expression of the proliferation marker Ki67 1 day post DOX treatment were seen in both cell types and were maintained throughout the time course (FC = 0.11 ± 0.07, P < 0.0001). Significant changes over the time course were also observed in mRNA expression of selected SASP factors (e.g. PAI‐1, MMP3, and IGFBP3, P < 0.05). Conclusions Neither cellular senescence nor sarcopenia is fully understood. The present data on human primary myoblasts and fibroblasts obtained from the same tissue sample show that senescence is a complex, non‐linear, and dynamic cellular process which shows intra‐ and inter‐cell variability." @default.
• W4282836413 created "2022-06-15" @default.
• W4282836413 creator A5022550984 @default.
• W4282836413 creator A5030770838 @default.
• W4282836413 creator A5037765310 @default.
• W4282836413 creator A5063486789 @default.
• W4282836413 creator A5086959747 @default.
• W4282836413 date "2022-06-14" @default.
• W4282836413 modified "2023-09-27" @default.
• W4282836413 title "Human primary skeletal muscle‐derived myoblasts and fibroblasts reveal different senescent phenotypes" @default.
• W4282836413 cites W1965342541 @default.
• W4282836413 cites W1972204726 @default.
• W4282836413 cites W1982481909 @default.
• W4282836413 cites W1982755288 @default.
• W4282836413 cites W1984419476 @default.
• W4282836413 cites W1992400237 @default.
• W4282836413 cites W2004314923 @default.
• W4282836413 cites W2010417927 @default.
• W4282836413 cites W2013306406 @default.
• W4282836413 cites W2022487205 @default.
• W4282836413 cites W2025957803 @default.
• W4282836413 cites W2036179779 @default.
• W4282836413 cites W2037048755 @default.
• W4282836413 cites W2039350499 @default.
• W4282836413 cites W2066644370 @default.
• W4282836413 cites W2070784200 @default.
• W4282836413 cites W2077475477 @default.
• W4282836413 cites W2099210995 @default.
• W4282836413 cites W2104689152 @default.
• W4282836413 cites W2105606616 @default.
• W4282836413 cites W2115852450 @default.
• W4282836413 cites W2129155846 @default.
• W4282836413 cites W2130458932 @default.
• W4282836413 cites W2146138975 @default.
• W4282836413 cites W2150748567 @default.
• W4282836413 cites W2212563976 @default.
• W4282836413 cites W2266290735 @default.
• W4282836413 cites W2286206290 @default.
• W4282836413 cites W2317055602 @default.
• W4282836413 cites W2323748919 @default.
• W4282836413 cites W2518802086 @default.
• W4282836413 cites W2603712266 @default.
• W4282836413 cites W2734636788 @default.
• W4282836413 cites W2765244546 @default.
• W4282836413 cites W2768033029 @default.
• W4282836413 cites W2802483327 @default.
• W4282836413 cites W2807039864 @default.
• W4282836413 cites W2860743873 @default.
• W4282836413 cites W2883070801 @default.
• W4282836413 cites W2888853423 @default.
• W4282836413 cites W2897513125 @default.
• W4282836413 cites W2901219010 @default.
• W4282836413 cites W2922300104 @default.
• W4282836413 cites W2925074929 @default.
• W4282836413 cites W2945475559 @default.
• W4282836413 cites W2988310131 @default.
• W4282836413 cites W2993497584 @default.
• W4282836413 cites W3010870651 @default.
• W4282836413 cites W3011574159 @default.
• W4282836413 cites W3099661466 @default.
• W4282836413 cites W3117525571 @default.
• W4282836413 cites W3167654775 @default.
• W4282836413 doi "https://doi.org/10.1002/rco2.67" @default.
• W4282836413 hasPublicationYear "2022" @default.
• W4282836413 type Work @default.
• W4282836413 citedByCount "3" @default.
• W4282836413 countsByYear W42828364132022 @default.
• W4282836413 countsByYear W42828364132023 @default.
• W4282836413 crossrefType "journal-article" @default.
• W4282836413 hasAuthorship W4282836413A5022550984 @default.
• W4282836413 hasAuthorship W4282836413A5030770838 @default.
• W4282836413 hasAuthorship W4282836413A5037765310 @default.
• W4282836413 hasAuthorship W4282836413A5063486789 @default.
• W4282836413 hasAuthorship W4282836413A5086959747 @default.
• W4282836413 hasBestOaLocation W42828364131 @default.
• W4282836413 hasConcept C126322002 @default.
• W4282836413 hasConcept C134018914 @default.
• W4282836413 hasConcept C1491633281 @default.
• W4282836413 hasConcept C153911025 @default.
• W4282836413 hasConcept C16685009 @default.
• W4282836413 hasConcept C189014844 @default.
• W4282836413 hasConcept C207200792 @default.
• W4282836413 hasConcept C2776214593 @default.
• W4282836413 hasConcept C2778106681 @default.
• W4282836413 hasConcept C2779959927 @default.
• W4282836413 hasConcept C35866371 @default.
• W4282836413 hasConcept C3763915 @default.
• W4282836413 hasConcept C522857546 @default.
• W4282836413 hasConcept C55493867 @default.
• W4282836413 hasConcept C71924100 @default.
• W4282836413 hasConcept C86803240 @default.
• W4282836413 hasConcept C95444343 @default.
• W4282836413 hasConceptScore W4282836413C126322002 @default.
• W4282836413 hasConceptScore W4282836413C134018914 @default.
• W4282836413 hasConceptScore W4282836413C1491633281 @default.
• W4282836413 hasConceptScore W4282836413C153911025 @default.
• W4282836413 hasConceptScore W4282836413C16685009 @default.
• W4282836413 hasConceptScore W4282836413C189014844 @default.

• next